LivePress.com
Pharmaceuticals News
Hospira net falls as expenses jump
YAHOO
Reuters - Hospira Inc. , which makes specialty pharmaceuticals and medication-delivery systems, on Wednesday said quarterly earnings fell 25 percent as sales were nearly flat and expenses surged.
Pharmaceuticals News
Barr to refile contraceptive bid within 2 weeks
YAHOO
Reuters - Barr Pharmaceuticals Inc. aims to resubmit its application to sell its Plan B morning-after contraceptive pill within two weeks, the company said on Tuesday, following a meeting with U.S. Food and Drug Administration officials.
Pharmaceuticals News
FDA, Barr to discuss looser Plan B sales
YAHOO
Reuters - The U.S. Food and Drug Administration and Barr Pharmaceuticals Inc. will meet to discuss the possible approval of nonprescription sales of the Plan B "morning-after" contraceptive to women 18 and older, the agency said on Monday.
Pharmaceuticals News
FDA to talk with Barr on Plan B proposal
YAHOO
Reuters - The U.S. Food and Drug Administration will meet with officials from Barr Pharmaceuticals Inc. to discuss the possible approval of nonprescription sales of the Plan B "morning-after" contraceptive to women 18 and older, the agency said on Monday.
Pharmaceuticals News
FDA clears AstraZeneca asthma drug
YAHOO
Reuters - AstraZeneca Plc has won U.S. approval for its asthma drug Symbicort, significantly earlier than most industry analysts had expected, a person familiar with the matter said on Saturday.
Categories Latest Pharmaceuticals News Related:
Business
Links
Trade links
Pharmaceuticals News Barr enters bidding race to buy Pliva: report
YAHOO
Reuters - U.S. drug maker Barr Pharmaceuticals has entered the bidding for Croatian pharmaceutical group Pliva (PLVxq.L), the Financial Times newspaper said on Monday.
Sources: YAHOO
Pharmaceuticals News Barr says Lilly sues to stop generic weekly Prozac
YAHOO
Reuters - Barr Pharmaceuticals Inc. on Thursday said Eli Lilly & Co. has sued the company, claiming Barr's generic weekly form of anti-depressant Prozac infringes the patent on Lilly's branded medicine.
Sources: YAHOO
Pharmaceuticals News Animal Rights Activists Target Glaxo Investors
AHN
Europe's biggest pharmaceuticals manufacturer, GlaxoSmithKline, says shareholders were told they would have their details posted on the internet if they did not sell their shares within 14 days in a threatening letter by animal rights...
Sources: AHN
Pharmaceuticals News Ariad's Shares Climb 40 Percent After It Wins Patent Case
AHN
Ariad Pharmaceuticals Inc. shares climbed up to 40 percent on Thursday after the company announced it won a patent infringement case against Eli Lilly and Co. Reuters reports a federal court in Massachusetts decided that Lilly's osteoporosis...
Sources: AHN
Pharmaceuticals News Texas plaintiffs seek over $1 bln in Vioxx case
YAHOO
Reuters - Attorneys suing Merck & Co. Inc. for the death of a 71-year-old man who took Vioxx asked a Texas jury on Thursday to award more than $1 billion in damages, but Merck lawyers said the pharmaceuticals company should not have to pay anything.
Sources: YAHOO
Pharmaceuticals News DrugMax announces preliminary Q1 results
YAHOO
Reuters - Pharmaceuticals distributor DrugMax Inc. reported preliminary results for the first quarter on Monday.
Sources: YAHOO
Pharmaceuticals News FDA halts Cortex's sleep drug trial, shares plunge
YAHOO
Reuters - Cortex Pharmaceuticals Inc. shares lost almost half of their value in morning trade Monday after the U.S. Food and Drug Administration placed the clinical trial of the company's sleep disorder drug on hold.
Sources: YAHOO
Pharmaceuticals News SGX forges leukemia cancer deal with Novartis
YAHOO
Reuters - SGX Pharmaceuticals Inc. late on Monday said Swiss drugmaker Novartis AG had licensed its experimental drugs to treat leukemia and could eventually pay it more than $515 million under the deal.
Sources: YAHOO
Pharmaceuticals News King may need new trial for Altace for kids
YAHOO
Reuters - King Pharmaceuticals, Inc. on Friday said U.S. regulators have determined that clinical data on use by children of its Altace hypertension drug was insufficient and a new trial may be needed.
Sources: YAHOO
Pharmaceuticals News Shire sues Teva over generic Adderall XR plans
YAHOO
Reuters - British drugmaker Shire Plc said on Friday it was suing Teva Pharmaceuticals over the Israeli drugmaker's plans to make a cheap, copycat version of hyperactivity drug Adderall XR.
Sources: YAHOO
Pharmaceuticals News King Pharma posts quarterly net loss
YAHOO
Reuters - Drugmaker King Pharmaceuticals Inc. on Tuesday posted a quarterly loss after taking a large charge tied to a research deal.
Sources: YAHOO
Pages:   [1]